Skip to content

Released Aug 5, 2019, after the close

10-Q filed Aug 5, 2019, 36 days after period end · 0001564590-19-028764

Q2 2019 · 10-Q
Revenue$115.85M+3.9% vs Q2 2018+6.2% vs Q1 2019
Net Income-$547.00KN/M vs Q2 2018N/M vs Q1 2019
EPS Diluted-$0.03N/M vs Q2 2018N/M vs Q1 2019
Gross Profit$90,038,000+1.5%
Operating Income$451,000−92.4%
Operating Cash Flowderived$9,383,000−43.4%
Free Cash Flowderived$4,431,000−67.5%
Margins · derived
Gross margin77.7%−1.8 pt vs Q2 2018
Operating margin0.4%−4.9 pt vs Q2 2018
Net margin-0.5%−1.3 pt vs Q2 2018

What the release said

The release

Same quarter

MetricQ2 2019Q2 2018Q2 2017Q2 2016
Revenue$115.85M$111.55M$108.94M$104.08M
Net Income-$547.00K$925.00K$3.85M-$7.44M
EPS Diluted-$0.03$0.05$0.21-$0.41

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR